Cardiology Market To Grow at CAGR 8.8%, Market Value to Reach USD 24.3 Billion By 2027
The report analyzes and forecasts the Cardiology Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Cardiology Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Cardiology Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Cardiology Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2496
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
Prominent players involved in cardiology market involve Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Terumo Corporation, Biosensors International Group, and among others
The major market segments of Cardiology Market are as below:
Market By Disease Indication
Hypertension
Hyperlipidemia
Arrhythmia
Others
Market By Medical Devices
Pacemakers
Implantable Cardioverter Defibrillators (ICDs)
Ventricular Assist Devices (VAD)
Cardiac Resynchronization Therapy (CRT) Devices
Heart Monitors
Stents
Catheters
Others
Market By Drug Type
Antihypertensive
Antihyperlipidemic
Anticoagulants
Antiplatelet drugs
Others
Market By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Cardiology
1.1. Definition and Scope
1.1.1. Definition of Cardiology
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cardiology Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cardiology Market By Disease Indication
1.2.3. Cardiology Market By Medical Devices
1.2.4. Cardiology Market By Drug Type
1.2.5. Cardiology Market By Distribution Channel
1.2.6. Cardiology Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2019
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Cardiology Market By Disease Indication
4.1. Introduction
4.2. Cardiology Revenue By Disease Indication
4.2.1. Cardiology Revenue (US$ Mn) and Forecast, By Disease Indication, 2016-2027
4.2.2. Hypertension
4.2.2.1. Hypertension Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Hyperlipidemia
4.2.3.1. Hyperlipidemia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Arrhythmia
4.2.4.1. Arrhythmia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Others
4.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Cardiology Market Revenue By Medical Devices
5.1. Introduction
5.2. Cardiology Revenue (US$ Mn) By Medical Devices
5.2.1. Cardiology Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
5.2.2. Pacemakers
5.2.2.1. Pacemakers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Implantable Cardioverter Defibrillators (ICDs)
5.2.3.1. Implantable Cardioverter Defibrillators (ICDs) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Ventricular Assist Devices (VAD)
5.2.4.1. Ventricular Assist Devices (VAD) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Cardiac Resynchronization Therapy (CRT) Devices
5.2.5.1. Cardiac Resynchronization Therapy (CRT) Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Heart Monitors
5.2.6.1. Heart Monitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Stents
5.2.7.1. Stents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Catheters
5.2.8.1. Catheters Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.9. Others
5.2.9.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Cardiology Market By Drug Type
6.1. Introduction
6.2. Cardiology Revenue (US$ Mn) By Drug Type
6.2.1. Cardiology Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
6.2.2. Antihypertensive
6.2.2.1. Antihypertensive Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Antihyperlipidemic
6.2.3.1. Antihyperlipidemic Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Anticoagulants
6.2.4.1. Anticoagulants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Antiplatelet drugs
6.2.5.1. Antiplatelet drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Others
6.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Cardiology Market By Distribution Channel
7.1. Introduction
7.2. Cardiology Revenue (US$) By Distribution Channel
7.2.1. Cardiology Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
7.3. Hospital Pharmacies
7.3.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Retail Pharmacies
7.4.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.5. Online Pharmacies
7.5.1. Online Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Cardiology Market By Country
8.1. North America Cardiology Overview
8.2. U.S.
8.2.1. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.2.2. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
8.2.3. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
8.2.4. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Canada
8.3.1. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.3.2. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
8.3.3. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
8.3.4. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Cardiology Market By Country
9.1. Europe Cardiology Market Overview
9.2. U.K.
9.2.1. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.2.2. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.2.3. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.2.4. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Germany
9.3.1. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.3.2. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.3.3. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.3.4. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. France
9.4.1. France Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.4.2. France Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.4.3. France Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.4.4. France Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.5. Spain
9.5.1. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.5.2. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.5.3. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.5.4. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.6.2. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.6.3. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.6.4. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Cardiology Market By Country
10.1. Asia Pacific Cardiology Market Overview
10.2. China
10.2.1. China Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
10.2.2. China Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
10.2.3. China Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
10.2.4. China Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.3. Japan
10.3.1. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
10.3.2. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
10.3.3. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
10.3.4. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.4. India
10.4.1. India Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
10.4.2. India Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
10.4.3. India Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
10.4.4. India Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.5. Australia
10.5.1. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
10.5.2. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
10.5.3. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
10.5.4. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.6. South Korea
10.6.1. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
10.6.2. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
10.6.3. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
10.6.4. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
10.7.2. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
10.7.3. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
10.7.4. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Cardiology Market By Country
11.1. Latin America Cardiology Market Overview
11.2. Brazil
11.2.1. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
11.2.2. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
11.2.3. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.2.4. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.3. Mexico
11.3.1. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
11.3.2. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
11.3.3. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.3.4. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
11.4.2. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
11.4.3. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
11.4.4. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
CHAPTER 12. Middle East & Africa Cardiology Market By Country
12.1. Middle East & Africa Cardiology Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
12.2.2. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
12.2.3. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
12.2.4. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.3. UAE
12.3.1. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
12.3.2. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
12.3.3. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
12.3.4. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 – 2027
12.4.2. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 – 2027
12.4.3. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 – 2027
12.4.4. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
CHAPTER 13. Player Analysis Of Cardiology
13.1. Cardiology Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Cardiology Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Medtronic plc
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Medtronic plc 2019 Cardiology Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Boston Scientific Corporation
14.3. Abbott Laboratories
14.4. Edwards Lifesciences
14.5. Cardinal Health
14.6. Terumo Corporation
14.7. Biosensors International Group
14.8. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2496
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
